Medical Devices; Exception from General Requirements for Informed Consent

ICR 201106-0910-006

OMB: 0910-0586

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2011-06-13
IC Document Collections
ICR Details
0910-0586 201106-0910-006
Historical Active 201005-0910-014
HHS/FDA
Medical Devices; Exception from General Requirements for Informed Consent
Revision of a currently approved collection   No
Regular
Approved without change 09/05/2011
Retrieve Notice of Action (NOA) 06/24/2011
  Inventory as of this Action Requested Previously Approved
09/30/2014 08/31/2013 08/31/2013
1,350 0 900
1,463 0 1,350
200 0 100

The information collections are associated with FDA's informed consent regulation, which provides an exception to the general requirement to obtain informed consent from the subject of an investigation involving an unapproved or not cleared in vitro diagnostic device intended to identify a chemical, biological, radiological, or nuclear agent. This regulation was issued under the statutory authority provided in section 520(g)(3)(D) of the Federal Food Drug and Cosmetic Act, which outlines the criteria under which an exemption from informed consent may be permissible.

Statute at Large: 21 Stat. 360 Name of Statute: null
  
US Code: 21 USC 360j Name of Law: Section 520

0910-AC25 Final or interim final rulemaking 76 FR 36989 06/24/2011

Yes

1
IC Title Form No. Form Name
Medical Devices; Exception from General Requirements for Informed Consent

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1,350 900 0 450 0 0
Annual Time Burden (Hours) 1,463 1,350 0 113 0 0
Annual Cost Burden (Dollars) 200 100 0 100 0 0
No
No
FDA is making one change to the interim final rule, in response to comments that the rule did not protect against misuse of this limited exception from informed consent requirements. In response to those concerns, FDA is adding one new requirement (amending the regulation) that investigators also send the documentation required in paragraph (e)(1) or (e)(2) to FDA, not just to the reviewing IRB. FDA has created this exception to help ensure that individuals who may have been exposed to a chemical, biological, radiological, or nuclear agent are able to benefit from the timely use of the most appropriate diagnostic devices, including those that are investigational. The final rule will add 150 respondents, 450 total annual responses, and 113 burden hours.

$0
No
No
No
No
No
Uncollected
Daniel Gitteson 3017965156 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
06/24/2011


© 2024 OMB.report | Privacy Policy